Trials / Completed
CompletedNCT04469777
Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
Evaluation of the Effect of Subcutaneous Injection of Erythropoietin on Visual Functions in Patients With Late Onset Optic Neuropathy
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Alexandria University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy.
Detailed description
Injury of the optic nerve or optic neuropathy is one of the most common causes of vision loss. This study aimed to investigate the therapeutic effect of subcutaneous erythropoietin in the management of late stage optic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | erythropoietin | Systemic erythropoietin injections (eprax 10000 IU subcutaneous twice daily for three days). |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2020-12-15
- Completion
- 2020-12-30
- First posted
- 2020-07-14
- Last updated
- 2021-04-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04469777. Inclusion in this directory is not an endorsement.